Current Environment: Production

Boston
617-738-6289
617-355-2079
Massachusetts
02115
300 Longwood Avenue
Location Page
/departments/cardiology

Education

Undergraduate School

Brown University

1986, Providence, RI

Medical School

Case Western Reserve University

1991, Cleveland, OH

Residency

Boston Children's Hospital

1994, Boston, MA

Fellowship

Boston Children's Hospital

1997, Boston, MA

Publications

  1. Donor History of Drug Use and Graft Survival in Pediatric Heart Transplant Recipients. JAMA Netw Open. 2025 Apr 01; 8(4):e257766. View Abstract

  2. Ventricular Assist Device Utilization for Children With Congenital Heart Disease: Still Bridging the Gap. J Am Coll Cardiol. 2025 Mar 04; 85(8):815-817. View Abstract

  3. From worries to resilience: a qualitative study of the psychosocial experiences of diverse adolescents and young adults with heart failure and their caregivers. Cardiol Young. 2025 Jan; 35(1):136-143. View Abstract

  4. Teaching pediatric cardiology fellows to communicate serious news: a pilot study. BMC Med Educ. 2024 Oct 07; 24(1):1092. View Abstract

  5. Socioeconomic Status and Major Adverse Transplant Events in Pediatric Heart Transplant Recipients. JAMA Netw Open. 2024 Oct 01; 7(10):e2437255. View Abstract

  6. Pathology of explanted pediatric hearts: An 11-year study. Population characteristics and implications for outcomes. Pediatr Transplant. 2024 Jun; 28(4):e14742. View Abstract

  7. The experience of fathers of children hospitalised with advanced heart disease. Cardiol Young. 2024 Jun; 34(6):1274-1278. View Abstract

  8. The Conduit to Improving Outcomes: Supporting the Vulnerable Myocardium in Hypoplastic Left Heart Syndrome. JACC Adv. 2024 Feb; 3(2):100809. View Abstract

  9. The family burden of paediatric heart disease during the chronic phase of illness. Cardiol Young. 2024 May; 34(5):997-1003. View Abstract

  10. Medium-term Outcomes in Pediatric Heart Transplant Recipients Managed Using a Steroid Avoidance Immune Suppression Protocol. Transplantation. 2024 01 01; 108(1):e8-e14. View Abstract

  11. The roles of preparation, location, and palliative care involvement in parent-perceived child suffering at the end of life. J Pediatr Nurs. 2023 Sep-Oct; 72:e166-e173. View Abstract

  12. The 2023 International Society for Heart and Lung Transplantation Guidelines for Mechanical Circulatory Support: A 10- Year Update. J Heart Lung Transplant. 2023 07; 42(7):e1-e222. View Abstract

  13. Medical and End-of-Life Decision-Making Preferences in Adolescents and Young Adults with Advanced Heart Disease and Their Parents. JAMA Netw Open. 2023 05 01; 6(5):e2311957. View Abstract

  14. Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device. ASAIO J. 2023 06 01; 69(6):e267-e269. View Abstract

  15. Patient and parent-reported outcomes in paediatric ventricular assist device support: a multi-center ACTION learning network feasibility and pilot experience. Cardiol Young. 2023 Nov; 33(11):2258-2266. View Abstract

  16. Palliative Care Across the Life Span for Children With Heart Disease: A Scientific Statement From the American Heart Association. Circ Cardiovasc Qual Outcomes. 2023 02; 16(2):e000114. View Abstract

  17. Finding the Words and Data to Discuss Donor Characteristics With Heart Transplant Recipients and Families: Reconsidering Risk. JAMA Cardiol. 2022 11 01; 7(11):1127-1128. View Abstract

  18. Prognostic Value of Exercise Stress Echocardiography in Pediatric Cardiac Transplant Recipients. J Am Soc Echocardiogr. 2022 11; 35(11):1133-1138.e2. View Abstract

  19. Parent-Provider Communication in Hospitalized Children with Advanced Heart Disease. Pediatr Cardiol. 2022 Dec; 43(8):1761-1769. View Abstract

  20. The Surprise Question as a Trigger for Primary Palliative Care Interventions for Children with Advanced Heart Disease. Pediatr Cardiol. 2022 Dec; 43(8):1822-1831. View Abstract

  21. Assessment of an Instrument to Measure Interdisciplinary Staff Perceptions of Quality of Dying and Death in a Pediatric Cardiac Intensive Care Unit. JAMA Netw Open. 2022 05 02; 5(5):e2210762. View Abstract

  22. Pediatric heart transplant waiting times in the United States since the 2016 allocation policy change. Am J Transplant. 2022 03; 22(3):833-842. View Abstract

  23. Obesity and dyslipidemia predict cardiac allograft vasculopathy and graft loss in children and adolescents post-heart transplant: A PHTS multi-institutional analysis. Pediatr Transplant. 2022 08; 26(5):e14244. View Abstract

  24. Self-reported quality of life in children with ventricular assist devices. Pediatr Transplant. 2022 06; 26(4):e14237. View Abstract

  25. Design and pilot testing of therapeutic clothing for hospitalized children. J Spec Pediatr Nurs. 2022 04; 27(2):e12363. View Abstract

  26. A "Good Death" for Children with Cardiac Disease. Pediatr Cardiol. 2022 Apr; 43(4):744-755. View Abstract

  27. Circumstances surrounding end-of-life in pediatric patients pre- and post-heart transplant: a report from the Pediatric Heart Transplant Society. Pediatr Transplant. 2022 Mar; 26(2):e14196. View Abstract

  28. Native Bicuspid Pulmonary Valve in D-Loop Transposition of the Great Arteries: Outcomes of the Neo-Aortic Valve Function and Root Dilation After Arterial Switch Operation. J Am Heart Assoc. 2021 09 21; 10(18):e021599. View Abstract

  29. Parent-Reported Symptoms and Perceived Effectiveness of Treatment in Children Hospitalized with Advanced Heart Disease. J Pediatr. 2021 Nov; 238:221-227.e1. View Abstract

  30. State of the science and future research directions in palliative and end-of-life care in paediatric cardiology: a report from the Harvard Radcliffe Accelerator Workshop. Cardiol Young. 2022 Mar; 32(3):431-436. View Abstract

  31. ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association. J Heart Lung Transplant. 2021 08; 40(8):709-732. View Abstract

  32. Burnout, professional fulfillment, and post-traumatic stress among pediatric solid organ transplant teams. Pediatr Transplant. 2021 Jun; 25(4):e14020. View Abstract

  33. Palliative Care Referrals in Cardiac Disease. Pediatrics. 2021 03; 147(3). View Abstract

  34. Parent and Physician Understanding of Prognosis in Hospitalized Children With Advanced Heart Disease. J Am Heart Assoc. 2021 01 19; 10(2):e018488. View Abstract

  35. Variability in clinical decision-making for ventricular assist device implantation in pediatrics. Pediatr Transplant. 2020 12; 24(8):e13840. View Abstract

  36. Fourth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report. Ann Thorac Surg. 2020 12; 110(6):1819-1831. View Abstract

  37. Comparison of tissue Doppler imaging and conventional echocardiography to discriminate rejection from non-rejection after pediatric heart transplantation. Pediatr Transplant. 2020 08; 24(5):e13738. View Abstract

  38. The re-occurrence of cardiomyopathy in propionic acidemia after liver transplantation. JIMD Rep. 2020 Jul; 54(1):3-8. View Abstract

  39. Extracorporeal Membrane Oxygenation Support After Heart Transplantation in Children-Outcomes of a Single Center Cohort. Pediatr Crit Care Med. 2020 04; 21(4):332-339. View Abstract

  40. Three-Dimensional Speckle Tracking Echocardiography for Assessment of Left Ventricular Function and Myocardial Mechanics after Pediatric Heart Transplantation. J Heart Lung Transplant. 2020 Apr; 39(4S):S457. View Abstract

  41. "How are You Doing?": Patient and Family Support Resources for Children on Ventricular Assist Device. J Heart Lung Transplant. 2020 Apr; 39(4S):S465. View Abstract

  42. Obesity Leads to Increased Mortality in Pediatric Heart Transplant Recipients - A Pediatric Heart Transplant Society Study. J Heart Lung Transplant. 2020 Apr; 39(4S):S85-S86. View Abstract

  43. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37. View Abstract

  44. Fears and Stressors of Trainees Starting Fellowship in Pediatric Cardiology. Pediatr Cardiol. 2020 Apr; 41(4):677-682. View Abstract

  45. Medical and end-of-life decision making in adolescents' pre-heart transplant: A descriptive pilot study. Palliat Med. 2020 03; 34(3):272-280. View Abstract

  46. Congenital Cardiothoracic Surgeons and Palliative Care: A National Survey Study. J Palliat Care. 2021 Jan; 36(1):17-21. View Abstract

  47. Integration of Pediatric Palliative Care Into Cardiac Intensive Care: A Champion-Based Model. Pediatrics. 2019 08; 144(2). View Abstract

  48. Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents. J Am Coll Cardiol. 2019 07 23; 74(3):346-358. View Abstract

  49. Is Doppler echocardiography useful for estimating left ventricular filling pressures in pediatric heart transplant recipients? Pediatr Transplant. 2019 11; 23(7):e13543. View Abstract

  50. Early outcomes for low-risk pediatric heart transplant recipients and steroid avoidance: A multicenter cohort study (Clinical Trials in Organ Transplantation in Children - CTOTC-04). J Heart Lung Transplant. 2019 09; 38(9):972-981. View Abstract

  51. Palliative care and paediatric cardiology: current evidence and future directions. Lancet Child Adolesc Health. 2019 07; 3(7):502-510. View Abstract

  52. Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: Preimplant Characteristics and Outcomes. Ann Thorac Surg. 2019 04; 107(4):993-1004. View Abstract

  53. Compassionate deactivation of ventricular assist devices in children: A survey of pediatric ventricular assist device clinicians' perspectives and practices. Pediatr Transplant. 2019 05; 23(3):e13359. View Abstract

  54. When a Child Needs a Transplant but Lacks Familial Social Support. Pediatrics. 2019 01; 143(1). View Abstract

  55. Ventricular Assist Device Support as a Bridge to Transplantation in Pediatric Patients. J Am Coll Cardiol. 2018 07 24; 72(4):402-415. View Abstract

  56. Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study. Am J Transplant. 2018 09; 18(9):2148-2162. View Abstract

  57. Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study. Am J Transplant. 2018 09; 18(9):2163-2174. View Abstract

  58. Study rationale, design, and pretransplantation alloantibody status: A first report of Clinical Trials in Organ Transplantation in Children-04 (CTOTC-04) in pediatric heart transplantation. Am J Transplant. 2018 09; 18(9):2135-2147. View Abstract

  59. Physician Perspectives on Palliative Care for Children with Advanced Heart Disease: A Comparison between Pediatric Cardiology and Palliative Care Physicians. J Palliat Med. 2018 06; 21(6):773-779. View Abstract

  60. Post-transplant outcomes in pediatric ventricular assist device patients: A PediMACS-Pediatric Heart Transplant Study linkage analysis. J Heart Lung Transplant. 2018 06; 37(6):715-722. View Abstract

  61. Liver abnormalities and post-transplant survival in pediatric Fontan patients. Pediatr Transplant. 2017 Dec; 21(8). View Abstract

  62. Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death. Hum Mol Genet. 2017 09 15; 26(18):3545-3552. View Abstract

  63. Patterns and Outcomes of Care in Children With Advanced Heart Disease Receiving Palliative Care Consultation. J Pain Symptom Manage. 2018 02; 55(2):351-358. View Abstract

  64. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017 Oct; 36(10):1080-1086. View Abstract

  65. Second annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: Pre-implant characteristics and outcomes. J Heart Lung Transplant. 2018 01; 37(1):38-45. View Abstract

  66. Pediatric Cardiology Provider Attitudes About Palliative Care: A Multicenter Survey Study. Pediatr Cardiol. 2017 Oct; 38(7):1324-1331. View Abstract

  67. The Evolution of a Pediatric Ventricular Assist Device Program: The Boston Children's Hospital Experience. Pediatr Cardiol. 2017 Jun; 38(5):1032-1041. View Abstract

  68. Deactivation of Ventricular Assist Devices: Perspectives and Experiences of Adult Cardiovascular Providers. J Card Fail. 2017 06; 23(6):485-486. View Abstract

  69. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). J Heart Lung Transplant. 2018 01; 37(1):89-99. View Abstract

  70. Trans-Fontan baffle placement of an endocardial systemic ventricular pacing lead. HeartRhythm Case Rep. 2017 Feb; 3(2):129-132. View Abstract

  71. Does Small Size Matter With Continuous Flow Devices?: Analysis of the INTERMACS Database of Adults With BSA =1.5 m2. JACC Heart Fail. 2017 02; 5(2):123-131. View Abstract

  72. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients. J Heart Lung Transplant. 2017 Apr; 36(4):434-442. View Abstract

  73. Palliative Care for Patients With End-Stage Cardiovascular Disease and Devices: A Report From the Palliative Care Working Group of the Geriatrics Section of the American College of Cardiology. JAMA Intern Med. 2016 07 01; 176(7):1017-9. View Abstract

  74. Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy? Pediatr Cardiol. 2016 Oct; 37(7):1200-10. View Abstract

  75. Report of the National Heart, Lung, and Blood Institute Working Group: An Integrated Network for Congenital Heart Disease Research. Circulation. 2016 Apr 05; 133(14):1410-8. View Abstract

  76. Adverse events in children implanted with ventricular assist devices in the United States: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):569-77. View Abstract

  77. Outcomes of children implanted with ventricular assist devices in the United States: First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):578-84. View Abstract

  78. Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: A report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS). J Heart Lung Transplant. 2016 05; 35(5):585-90. View Abstract

  79. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Circ Heart Fail. 2016 Jan; 9(1):e002328. View Abstract

  80. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015 Dec; 34(12):1495-504. View Abstract

  81. Pediatric mechanical circulatory support: available devices and outcomes as bridge-to-transplant therapy. Curr Opin Organ Transplant. 2015 Oct; 20(5):557-61. View Abstract

  82. Physician and parent perceptions of prognosis and end-of-life experience in children with advanced heart disease. J Palliat Med. 2015 Apr; 18(4):318-23. View Abstract

  83. Adrenergic receptor genotype influences heart failure severity and ß-blocker response in children with dilated cardiomyopathy. Pediatr Res. 2015 Feb; 77(2):363-9. View Abstract

  84. Association of hemodynamic profiles with wait-list mortality in children listed for heart transplantation with idiopathic dilated cardiomyopathy. Am J Cardiol. 2015 Jan 15; 115(2):243-8. View Abstract

  85. Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer. 2015 02; 62(2):214-218. View Abstract

  86. Parental perspectives on suffering and quality of life at end-of-life in children with advanced heart disease: an exploratory study*. Pediatr Crit Care Med. 2014 May; 15(4):336-42. View Abstract

  87. Risk factors and outcome of Fontan-associated plastic bronchitis: a case-control study. J Am Heart Assoc. 2014 Apr 22; 3(2):e000865. View Abstract

  88. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant. 2014 Jun; 33(6):555-64. View Abstract

  89. Ventricular assist devices in children: progress with an orphan device application. Circulation. 2014 Apr 08; 129(14):1530-7. View Abstract

  90. Survival in patients removed from the heart transplant waiting list before receiving a transplant. J Heart Lung Transplant. 2014 Mar; 33(3):261-9. View Abstract

  91. Tissue Doppler imaging for rejection surveillance in pediatric heart transplant recipients. J Heart Lung Transplant. 2013 Oct; 32(10):1027-33. View Abstract

  92. Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients. Pediatr Transplant. 2013 Nov; 17(7):661-9. View Abstract

  93. Prognostic value of exercise testing during heart transplant evaluation in children. Circ Heart Fail. 2013 Jul; 6(4):792-9. View Abstract

  94. Ten yr of pediatric heart transplantation: a report from the Pediatric Heart Transplant Study. Pediatr Transplant. 2013 Mar; 17(2):99-111. View Abstract

  95. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013 Jan 22; 127(3):331-9. View Abstract

  96. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. J Heart Lung Transplant. 2012 Dec; 31(12):1241-52. View Abstract

  97. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Circ Heart Fail. 2013 Jan; 6(1):145-50. View Abstract

  98. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Circ Heart Fail. 2013 Jan; 6(1):e1-e11. View Abstract

  99. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Ann Thorac Surg. 2012 Dec; 94(6):e163-8. View Abstract

  100. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Ann Thorac Surg. 2012 Dec; 94(6):2147-58. View Abstract

  101. Cardiac allograft function during the first year after transplantation in rejection-free children and young adults. Circ Cardiovasc Imaging. 2012 Nov; 5(6):756-64. View Abstract

  102. Allograft-Transmitted Histoplasma capsulatum Infection in a Solid Organ Transplant Recipient. J Pediatric Infect Dis Soc. 2013 Sep; 2(3):270-3. View Abstract

  103. Patterns of care at end of life in children with advanced heart disease. Arch Pediatr Adolesc Med. 2012 Aug; 166(8):745-8. View Abstract

  104. Utility of exercise stress echocardiography in pediatric cardiac transplant recipients: a single-center experience. J Heart Lung Transplant. 2012 May; 31(5):517-23. View Abstract

  105. Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant. 2012 Apr; 31(4):398-409. View Abstract

  106. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the Pediatric Heart Transplant Study. J Heart Lung Transplant. 2012 Feb; 31(2):133-9. View Abstract

  107. Sudden death after pediatric heart transplantation: analysis of data from the Pediatric Heart Transplant Study Group. J Heart Lung Transplant. 2011 Dec; 30(12):1395-402. View Abstract

  108. Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale. Am Heart J. 2011 Sep; 162(3):425-35.e6. View Abstract

  109. Association of graft ischemic time with survival after heart transplant among children in the United States. J Heart Lung Transplant. 2011 Nov; 30(11):1244-9. View Abstract

  110. Outcomes after listing for primary transplantation for infants with unoperated-on non-hypoplastic left heart syndrome congenital heart disease: a multi-institutional study. J Heart Lung Transplant. 2011 Sep; 30(9):1023-32. View Abstract

  111. The impact of heart failure severity at time of listing for cardiac transplantation on survival in pediatric cardiomyopathy. J Heart Lung Transplant. 2011 Jul; 30(7):755-60. View Abstract

  112. Changes in echocardiographic measures of systolic and diastolic function in children 1 year after hematopoietic SCT. Bone Marrow Transplant. 2011 Dec; 46(12):1532-9. View Abstract

  113. Patterns of End-of-Life Care in Children with Advanced Heart Disease (747). J Pain Symptom Manage. 2011 Jan; 41(1):301. View Abstract

  114. Infection and malignancy after pediatric heart transplantation: the role of induction therapy. J Heart Lung Transplant. 2011 Mar; 30(3):299-308. View Abstract

  115. Rejection with hemodynamic compromise in the current era of pediatric heart transplantation: a multi-institutional study. J Heart Lung Transplant. 2011 Mar; 30(3):282-8. View Abstract

  116. Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data. J Heart Lung Transplant. 2011 Feb; 30(2):151-7. View Abstract

  117. Association of race and socioeconomic position with outcomes in pediatric heart transplant recipients. Am J Transplant. 2010 Sep; 10(9):2116-23. View Abstract

  118. Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome. J Heart Lung Transplant. 2010 Nov; 29(11):1226-30. View Abstract

  119. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial. Circ Heart Fail. 2010 Sep; 3(5):606-11. View Abstract

  120. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis. Circulation. 2010 May 04; 121(17):1926-33. View Abstract

  121. Decline in rejection in the first year after pediatric cardiac transplantation: a multi-institutional study. J Heart Lung Transplant. 2010 Jun; 29(6):625-32. View Abstract

  122. Use of a virtual community as a psychosocial support system in pediatric transplantation. Pediatr Transplant. 2010 Mar; 14(2):261-7. View Abstract

  123. Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients. J Heart Lung Transplant. 2010 May; 29(5):517-22. View Abstract

  124. Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant. 2009 Dec; 9(12):2808-15. View Abstract

  125. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009 Dec; 28(12):1292-8. View Abstract

  126. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg. 2009 Aug; 88(2):558-63; discussion 563-4. View Abstract

  127. Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail. 2009 May; 2(3):160-5. View Abstract

  128. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009 Feb 10; 119(5):717-727. View Abstract

  129. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009 Jan; 28(1):44-50. View Abstract

  130. The longitudinal course of cardiomyopathy in Friedreich's ataxia during childhood. Pediatr Cardiol. 2009 Apr; 30(3):306-10. View Abstract

  131. Ventricular assist devices as a bridge to heart transplantation in children. J Cardiovasc Nurs. 2008 Jan-Feb; 23(1):25-9. View Abstract

  132. Intra-aortic balloon pump use in the failing Fontan circulation. Congenit Heart Dis. 2008 Jan-Feb; 3(1):60-2. View Abstract

  133. Longitudinal changes in heart rate recovery after maximal exercise in pediatric heart transplant recipients: evidence of autonomic re-innervation? J Heart Lung Transplant. 2007 Dec; 26(12):1306-12. View Abstract

  134. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007 Sep 12; 298(10):1171-9. View Abstract

  135. Outcome after Fontan failure and takedown to an intermediate palliative circulation. Ann Thorac Surg. 2007 Sep; 84(3):880-7. View Abstract

  136. Parenting stress and parental post-traumatic stress disorder in families after pediatric heart transplantation. J Heart Lung Transplant. 2007 Feb; 26(2):120-6. View Abstract

  137. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007 Feb 06; 115(5):658-76. View Abstract

  138. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia. J Heart Lung Transplant. 2006 Nov; 25(11):1376-9. View Abstract

  139. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006 Jul 25; 114(4):273-80. View Abstract

  140. Successful implantation of a Berlin heart biventricular assist device in a failing single ventricle. J Thorac Cardiovasc Surg. 2006 Jun; 131(6):1407-8. View Abstract

  141. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006 May 16; 113(19):2313-9. View Abstract

  142. Prospective single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol. 2006 May-Jun; 27(3):336-42. View Abstract

  143. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet. 2006 Jan 21; 367(9506):233-9. View Abstract

  144. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant. 2004 Dec; 23(12):1313-33. View Abstract

  145. The longitudinal impact of psychological functioning, medical severity, and family functioning in pediatric heart transplantation. J Heart Lung Transplant. 2004 Apr; 23(4):473-80. View Abstract

  146. Risk factors for recurrent rejection in pediatric heart transplantation: a multicenter experience. J Heart Lung Transplant. 2004 Feb; 23(2):178-85. View Abstract

  147. Current status of heart transplantation in children: update 2003. Pediatr Clin North Am. 2003 Dec; 50(6):1375-91. View Abstract

  148. Atrial tachyarrhythmias and permanent pacing after pediatric heart transplantation. J Heart Lung Transplant. 2003 Oct; 22(10):1126-33. View Abstract

  149. Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A. Intensive Care Med. 2003 Jun; 29(6):985-988. View Abstract

  150. Gastrointestinal complications after pediatric cardiac transplantation. J Heart Lung Transplant. 2002 Jul; 21(7):751-9. View Abstract

  151. Arterial switch operation with a single coronary artery. J Thorac Cardiovasc Surg. 2002 Jun; 123(6):1164-72. View Abstract

  152. Endothelial COX-2 induction by hypoxia liberates 6-keto-PGF1 alpha, a potent epithelial secretagogue. Adv Exp Med Biol. 2002; 507:107-12. View Abstract

  153. Giant cell myocarditis in a 12-year-old girl with common variable immunodeficiency. Mayo Clin Proc. 2002 Jan; 77(1):92-6. View Abstract

  154. Perioperative risk factors for development of protein-losing enteropathy following a Fontan procedure. Am J Cardiol. 2001 Nov 15; 88(10):1206-9. View Abstract

  155. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr. 2001 Apr; 138(4):505-11. View Abstract

  156. Clinical outcome of fenestrated Fontan patients after closure: the first 10 years. Circulation. 2000 Oct 24; 102(17):2094-9. View Abstract

  157. Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia. Ann Thorac Surg. 2000 Sep; 70(3):890-4. View Abstract

  158. Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support. Ann Thorac Surg. 2000 Jan; 69(1):186-92. View Abstract

  159. Left superior vena cava connection to unroofed coronary sinus associated with positional cyanosis: successful transcatheter treatment using Gianturco-Grifka vascular occlusion device. Catheter Cardiovasc Interv. 1999 Dec; 48(4):369-73. View Abstract

  160. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations. Am J Med Genet. 1999 Oct 29; 86(5):470-6. View Abstract

  161. Evolution of risk factors influencing early mortality of the arterial switch operation. J Am Coll Cardiol. 1999 May; 33(6):1702-9. View Abstract

  162. Activated endothelial cells elicit paracrine induction of epithelial chloride secretion. 6-Keto-PGF1alpha is an epithelial secretagogue. J Clin Invest. 1998 Sep 15; 102(6):1161-72. View Abstract

  163. Images in cardiovascular medicine. Anatomically corrected malposition of the great arteries [S,D,L]. Circulation. 1998 Mar 31; 97(12):1207. View Abstract

  164. Long-term results of arterial switch repair of transposition of the great vessels. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 1998; 1:129-138. View Abstract

  165. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass. Circulation. 1997 Nov 04; 96(9 Suppl):II-352-7. View Abstract

  166. A switch in time saves a statistical bind. JAMA. 1991 Dec 18; 266(23):3284-5. View Abstract

  167. Amnesic patients give clues on structure of memory. JAMA. 1983 Oct 07; 250(13):1662-3. View Abstract

  168. Palliation may block cure of incontinence in elderly. JAMA. 1983 Sep 16; 250(11):1371. View Abstract

  169. Elderly patient needs assessment, not neglect. JAMA. 1983 Sep 02; 250(9):1132-3. View Abstract

  170. Street drugs yield primate Parkinson's model. JAMA. 1983 Jul 01; 250(1):13-4. View Abstract

  171. Premenstrual syndromes, depression linked. JAMA. 1983 Jun 03; 249(21):2864-6. View Abstract

  172. Sound, shock waves shatter kidney stones. JAMA. 1983 May 13; 249(18):2434-5. View Abstract

  173. Ambulatory dialysis: special boon for children. JAMA. 1983 May 06; 249(17):2290-1. View Abstract

  174. 'Tricks' of trade aid kidney transplants. JAMA. 1983 May 06; 249(17):2288-90. View Abstract

  175. Promising agents for limiting renal damage. JAMA. 1983 Apr 15; 249(15):1987. View Abstract

Education

Undergraduate School

Williams College

1989, Williamstown, MA

Graduate School

Bryn Mawr College

1991, Bryn Mawr, PA

Medical School

Harvard Medical School

1996, Boston, MA

Internship

Boston Children's Hospital

1997, Boston, MA

Residency

Boston Children's Hospital

1999, Boston, MA

Fellowship

Boston Children's Hospital

2003, Bosotn, MA

Publications
Subscribe to Department of Cardiology

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000.

I am unable to answer specific questions regarding your child's case, including appointments and conditions/diagnosis. Please contact your physician's office.

Quick links:

- MyChildrens Portal
- Global Services
- Find a Doctor
- Find a Location
- Programs and Services